Identification of strains of rotateq rotavirus vaccine in infants with gastroenteritis following routine vaccination

Journal of Infectious Diseases

Volumn 206, Issue 3, 2012, Pages 377-383

  Donato, Celeste M ^a,b   Ch'Ng, Ling Sing ^a,c   Boniface, Karen F ^a   Crawford, Nigel W ^a,c   Buttery, Jim P ^a,d   Lyon, Michael ^e   Bishop, Ruth F ^a,c   Kirkwood, Carl D ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e Queensland Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; DOT HYBRIDIZATION; DRUG EXCRETION; FECES ANALYSIS; GASTROENTERITIS; GENE SEQUENCE; GENETIC REASSORTMENT; GENETIC SCREENING; GENOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NORTHERN BLOTTING; PRIORITY JOURNAL; ROTAVIRUS; SEQUENCE ANALYSIS; VACCINATION REACTION; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; VP3 GENE; VP4 GENE; VP6 GENE; VP7 GENE;

AUSTRALIA; CAPSID PROTEINS; FECES; GASTROENTERITIS; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HUMANS; INFANT; REASSORTANT VIRUSES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 84862545598     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis361     Document Type: Article

References (41)

1. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-32.
2. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis 2009; 200: S9-15.
3. Estes MK. Rotaviruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Fields virology. 3rd ed. Vol 2. Philadelphia: Lippincott-Raven 1996; 1625-55.
4. Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implications for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005; 15:29-56.
5. Kirkwood CD. Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs. J Infect Dis 2010; 202: S43-8.
6. Ward RL. Rotavirus vaccines; how they work or don't work. Exp Rev Mol Med 2008; 10:1-14.
7. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis 2008; 8:642-9.
8. Desselberger U, Manktelow E, Li W, Cheung W, Iturriza-Gomara M, Gray J. Rotaviruses and rotavirus vaccines. Br Med Bull 2009; 90:37-51.
9. Parez N. Rotavirus gastroenteritis: why to back up the development of new vaccines? Comp Immunol Microb 2008; 31:253-69.
10. Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis 2009; 48:222-8.
11. Heaton PM, Ciarlet M. The pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis 2007; 45:1618-24.
12. Richardson S, Grimwood K, Gorrell R, Palombo E, Barnes G, Bishop R. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998; 351:1844-8.
13. Dennehy PH, Goveia MG, Dallas MJ, Heaton PM. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int J Infect Dis 2007; 11:S36-42.
14. Yen C, Jakob K, Esona MD, et al. Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine. Vaccine 2011; 29:4151-5.
15. Galati JC, Harsley S, Richmond P, Carlin JB. The burden of rotavirusrelated illness among young children on the Australian health care system. Aust NZ J Public Health 2006; 30:416-21.
16. Buttery JP, Lambert SB, Grimwood K, et al. Reduction in rotavirusassociated acute gastroenteritis following introduction of rotavirus vaccine into Australia's national childhood vaccine schedule. Pediatr Infect Dis J 2011; 30:S25-9.
17. Macartney KK, Porwal M, Dalton D, et al. Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. J Paediatr Child Health 2011; 47:266-70.
18. Elschner M, Prudlo J, Hotzel H, Otto P, Sachse K. Nested reverse transcriptase-polymerase chain reaction for the detection of group A rotaviruses. J Vet Med B 2002; 49:77-81.
19. Gouvea V, Glass RI, Woods P, et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. J Clin Microbiol 1990; 28:276-82.
20. Iturriza-Gómara M, Kang G, Gray J. Rotavirus genotyping: keeping up with an evolving population of human rotaviruses. J Clin Virol 2004; 31:259-65.
21. Gentsch JR, Glass RI, Woods P, et al. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J Clin Microbiol 1992; 30:1365-73.
22. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 2008; 42:368-73.
23. Kirkwood CD, Boniface K, Barnes GL, Bishop RF. Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix and RotaTeq, into the national immunization program of Australia. Pediatr Infect Dis J 2011; 30:S48-53.
24. Isegawa Y, Nakagomi O, Nakagomi T, Ueda S. A VP4 sequence highly conserved in human rotavirus strain AU-1 and feline rotavirus strain FRV-1. J Gen Virol 1992; 7:1939-46.
25. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-9.
26. Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. Immunisation coverage annual report 2008. Commun Dis Intell 2010; 34:241-58.
27. Lambert SB, Faux CE, Hall L, et al. Early evidence for direct and indirect effects of the infant rotavirus vaccine program in Queensland. Med J Aust 2009; 191:157-9.
28. Fields EJ, Vally H, Grimwood K, Lambert SB. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics 2010; 126:506-12.
29. Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J 2011; 30:S1-5.
30. Tate JE, Patel MM, Steele AD, et al. Global impact of rotavirus vaccines. Expert Rev Vaccines 2010; 9:395-407.
31. Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine 2011; 29:8141-6.
32. Matthijnssens J, Joelsson DB, Warakomski DJ, et al. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq. Virology 2010; 403:111-27.
33. Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics 2010; 125:438-41.
34. McDonald SM, Matthijnssens J, McAllen JK, et al. Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathogens 2009; 5:e1000634.
35. Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal strains: implications for rotavirus vaccine programs. J Infect Dis 2005; 192:S146-59.
36. Matthijnssens J, Taraporewala ZF, Yang H, et al. Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment. J Virol 2010; 84:2013-26.
37. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009. Clin Infect Dis 2011; 53:245-53.
38. Rivera L, Peña LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain-a randomized, placebo-controlled study in twins. Vaccine 2011; 29:9508-13.
39. Werther RL, Crawford NW, Boniface K, Kirkwood CD, Smart JM. Rotavirus vaccine induced diarrhea in a child with severe combined immune deficiency. J Allergy Clin Immunol 2009; 124:600.
40. Bakare N, Menschik D, Tiernan R, Hua W, Martin D. Severe combined immunodeficiency (SCID) and rotavirus vaccination: reports to the Vaccine Adverse Events Reporting System (VAERS). Vaccine 2010; 28:6609-12.
41. Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine. MMWR Morb Mortal Wkly Rep 2010; 59:687-8.